- Home
- ADMA vs SON Comparison
ADMA vs SON Comparison
Compare ADMA & SON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- SON
- Stock Information
- Founded
- ADMA 2004
- SON 1899
- Country
- ADMA United States
- SON United States
- Employees
- ADMA N/A
- SON N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- SON Containers/Packaging
- Sector
- ADMA Health Care
- SON Consumer Discretionary
- Exchange
- ADMA Nasdaq
- SON Nasdaq
- Market Cap
- ADMA 5.1B
- SON 4.3B
- IPO Year
- ADMA N/A
- SON N/A
- Fundamental
- Price
- ADMA $19.33
- SON $44.24
- Analyst Decision
- ADMA Strong Buy
- SON Strong Buy
- Analyst Count
- ADMA 3
- SON 8
- Target Price
- ADMA $27.67
- SON $57.63
- AVG Volume (30 Days)
- ADMA 2.4M
- SON 1.1M
- Earning Date
- ADMA 08-06-2025
- SON 07-23-2025
- Dividend Yield
- ADMA N/A
- SON 4.80%
- EPS Growth
- ADMA N/A
- SON 50.35
- EPS
- ADMA 0.84
- SON 5.59
- Revenue
- ADMA $459,381,000.00
- SON $6,337,597,000.00
- Revenue This Year
- ADMA $21.11
- SON $46.12
- Revenue Next Year
- ADMA $25.97
- SON $0.72
- P/E Ratio
- ADMA $23.13
- SON $7.91
- Revenue Growth
- ADMA 62.23
- SON 28.33
- 52 Week Low
- ADMA $10.21
- SON $39.46
- 52 Week High
- ADMA $25.67
- SON $56.77
- Technical
- Relative Strength Index (RSI)
- ADMA 62.08
- SON 38.32
- Support Level
- ADMA $16.77
- SON $47.35
- Resistance Level
- ADMA $18.41
- SON $50.09
- Average True Range (ATR)
- ADMA 0.67
- SON 1.17
- MACD
- ADMA 0.26
- SON -0.32
- Stochastic Oscillator
- ADMA 96.26
- SON 3.31
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About SON Sonoco Products Company
Over its 100-year-plus history, Sonoco Products has steadily assembled a diverse portfolio of industrial and consumer packaging product offerings such as flexible and rigid plastics, reels and spools, pallets, and composite cans. The company serves a variety of consumer and industrial end markets throughout North America. Sonoco has raised its dividend each year for more than 40 years.